Suchergebnisse - "Generali, D"

PubPharm (6)

1

Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer : incidence and time course of adverse events in the phase IIIb BALLET population

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2020

von Ciruelos, E. | Jerusalem, G. | Martin, M. | +9

2

Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

enthalten in: Clinical and translational oncology | 2020

von Ciruelos, E. | Jerusalem, G. | Martin, M. | +9

3

Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

enthalten in: Clinical & translational oncology | 2020

von Ciruelos, E. | Jerusalem, G. | Martin, M. | +9

4

Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

enthalten in: Revista de oncología | 2020

von Ciruelos, E. | Jerusalem, G. | Martin, M. | +9

5

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients : New insights beyond clinical trials. The EVA study

enthalten in: Breast (Edinburgh, Scotland) | 2017

von Cazzaniga, M. | Airoldi, M. | Arcangeli, V. | +68

6

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors : primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2016

von Jerusalem, G. | Mariani, G. | Ciruelos, E. | +15

1
[1]